Written by The Gamma Knife Market is developing alongside advances in stereotactic radiosurgery, medical imaging, and precision treatment technologies. The market is projected to increase from USD 0.5866 billion in 2025 to USD 0.974 billion by 2035 at a CAGR of 5.2%. Growing investment in healthcare infrastructure and increasing demand for targeted therapies are supporting this expansion.
Gamma Knife systems provide a non-invasive approach for delivering focused radiation to specific areas, making them relevant for the management of selected brain tumors and neurological disorders. Increasing patient and provider interest in treatments associated with shorter recovery times is contributing to demand. Improvements in imaging integration and software-based treatment planning are further enhancing system capabilities.
Brain metastasis remains the largest disease-indication segment, while cancer is the fastest-growing segment according to MRFR. Other important applications include arteriovenous malformation and trigeminal neuralgia. By anatomy, head treatments dominate, while the neck segment is identified as an emerging area of growth as targeted radiation approaches gain attention for selected head and neck conditions.
Regionally, North America accounts for approximately 45% of the global market, Europe holds around 30%, and Asia-Pacific represents approximately 20%. Asia-Pacific is experiencing increasing adoption as countries expand healthcare infrastructure and invest in advanced cancer and neurological treatment technologies. Continued innovation, specialized treatment centers, and healthcare partnerships are expected to influence the market through 2035.
Explore additional reports to understand evolving market landscapes:
Healthcare Gamification Market Size
Healthcare Gamification Market Share